The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as ...

Mainz, 22 July 2025. Boehringer Ingelheim Stiftung commits 7 million euros to support the EMBL Imaging Centre in Heidelberg. Boehringer Ingelheim Stiftung, Dr Friederike Keggenhoff, Officer, Web: ...

LEO Pharma and Boehringer Ingelheim have entered into a partnership to commercialise and advance the development of ...

Philadelphia, PA, July 21, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

As the largest animal shelter in eastern South Dakota, the Humane Society cares for more than 8,000 animals annually.

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

Boehringer Ingelheim and SoundTalks end their partnership, but what does this mean for pig farmers? Find out about the future ...

the white paper underscores a widespread crisis of underappreciation, operational strain and burnout, directly impacting the ...

In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...

Boehringer Ingelheim announces the start of the THULITE Phase II clinical study. It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision ...